Abstract
The aim of this mini-review is to highlight the current state of the problem of nosocomial pneumonia and nosocomial tracheobronchitis in critically ill patients. The important concepts for nosocomial tracheobronchitis, novel genetic and molecular biomarkers of nosocomial pneumonia and nosocomial tracheobronchitis and the role of inhaled antibiotics in the treatment of this condition and their ability to prevent the development of nosocomial pneumonia are discussed.
Keywords: Colistin, inhaled antibiotics, nosocomial pneumonia, nosocomial tracheobronchitis, tobramycin, respiratory tract.
Current Respiratory Medicine Reviews
Title:Nosocomial Tracheobronchitis and Pneumonia Continuum - Target for Inhaled Antibiotics?
Volume: 14 Issue: 3
Author(s): Artem Kuzovlev*, Aslan Shabanov, Tamara Smelaya, Arkady Goloubev, Viktor Moroz, Sergey Petrikov and Andrey Grechko
Affiliation:
- Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow,Russian Federation
Keywords: Colistin, inhaled antibiotics, nosocomial pneumonia, nosocomial tracheobronchitis, tobramycin, respiratory tract.
Abstract: The aim of this mini-review is to highlight the current state of the problem of nosocomial pneumonia and nosocomial tracheobronchitis in critically ill patients. The important concepts for nosocomial tracheobronchitis, novel genetic and molecular biomarkers of nosocomial pneumonia and nosocomial tracheobronchitis and the role of inhaled antibiotics in the treatment of this condition and their ability to prevent the development of nosocomial pneumonia are discussed.
Export Options
About this article
Cite this article as:
Kuzovlev Artem*, Shabanov Aslan, Smelaya Tamara, Goloubev Arkady, Moroz Viktor, Petrikov Sergey and Grechko Andrey, Nosocomial Tracheobronchitis and Pneumonia Continuum - Target for Inhaled Antibiotics?, Current Respiratory Medicine Reviews 2018; 14 (3) . https://dx.doi.org/10.2174/1573398X14666181019121945
DOI https://dx.doi.org/10.2174/1573398X14666181019121945 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Potential Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies
Current Medicinal Chemistry Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors
Current Topics in Medicinal Chemistry Nephrotonic and Nephroprotective Medicinal Herbs in Traditional Persian Medicine: Review and Assessment of Scientific Evidence
Current Traditional Medicine Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Proniosomes in Transdermal Drug Delivery
Current Pharmaceutical Design Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Physical Means of Stratum Corneum Barrier Manipulation to Enhance Transdermal Drug Delivery
Current Drug Delivery Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity
Current Respiratory Medicine Reviews Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Anti-Infective Agents Dexrazoxane for the Prevention of Cardiac Toxicity and Treatment of Extravasation Injury from the Anthracycline Antibiotics
Current Pharmaceutical Biotechnology The Nutrigenetics and Pharmacogenetics of Vitamin D Pathways
Current Pharmacogenomics and Personalized Medicine Oxidative Stress, Histone Deacetylase and Corticosteroid Resistance in Severe Asthma and COPD
Current Respiratory Medicine Reviews Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Current Gene Therapy Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design Current Prospective of Aldose Reductase Inhibition in the Therapy of Allergic Airway Inflammation in Asthma
Current Molecular Medicine Feasibility of FDG PET in Inflammatory Bowel Disease
Current Molecular Imaging (Discontinued) Drug Targets in Herpes Simplex and Epstein Barr Virus Infections
Infectious Disorders - Drug Targets Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
Current Pharmaceutical Design Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism